*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>(6S)-6-[5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid</strong> is a chiral intermediate synthesized via spirocyclization and halogenation for advanced pharmaceutical development. Molecular formula: C<sub>22</sub>H<sub>14</sub>BrFN<sub>3</sub>O<sub>2</sub>. CAS No.: Pending verification.</p>
<h3>Application</h3>
<ul>
<li>Targeted oncology drug synthesis as a scaffold for kinase inhibitors.</li>
<li>Research into novel antifungal agents with improved metabolic stability.</li>
<li>Custom manufacturing of complex heterocyclic APIs for contract labs.</li>
</ul>
<h3>Precautions</h3>
<p>Requires storage under inert atmosphere at -20°C. Strictly for R&D use; not approved for clinical administration. Handle with appropriate PPE to avoid inhalation or skin contact.</p>